Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

BATPROTECT

Financiado

Cerrado

Learning from Bats: New Strategies to Extend Healthspan and Improve Disease Resi...

Learning from Bats: New Strategies to Extend Healthspan and Improve Disease Resistance The medical, financial, and emotional costs imposed by ageing and infectious diseases are major challenges for our societies. Strikingly, while past research has not provided solutions for extending human healthspan and preventing... ver más

31/05/2030

NUID UCD

12M€

Presupuesto del proyecto: 12M€

Líder del proyecto

UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-06-01

ERC-2023-SyG: ERC Synergy Grants Objective:The aim is to provide support for a small group of two to four Principal Investigators to...

I+D

Cerrada hace 2 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

NUID UCD

Lider

Proyectos interesantes

AGELESS

Medical Technol...

Data Science

1M€ Cerrado

ElucidAge

Medical Technol...

Data Science

2M€ Cerrado

BFU2015-68649-P

Medical Technol...

Data Science

190K€ Cerrado

IDEAL

Medical Technol...

Data Science

16M€ Cerrado

EUROBATS

Medical Technol...

Data Science

4M€ Cerrado

ImAgine

Medical Technol...

Data Science

1M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 71 meses Fecha Inicio: 2024-06-01
Fecha Fin: 2030-05-31

Líder del proyecto

UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 12M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The medical, financial, and emotional costs imposed by ageing and infectious diseases are major challenges for our societies. Strikingly, while past research has not provided solutions for extending human healthspan and preventing the harmful consequences of infections, nature has solved both problems in the only flying mammals – the bats. Among mammals, bats exhibit an exceptional longevity with little signs of age-related diseases. Despite being reservoirs for numerous deadly viruses, viral infections in bats are mostly asymptomatic due to unique immune system adaptations. The overarching goal of BATPROTECT is to achieve breakthroughs in our understanding of the molecular basis of bats’ extended healthspan and disease resistance to ultimately discover new directions to improve human healthspan and disease outcome. BATPROTECT integrates a team of world-leading experts in bat biology, genomics, immunology and gerontology to synergistically: (i) elucidate the molecular mechanisms that bats use to slow down expected ageing; (ii) identify the driving molecular mechanisms behind bats’ viral tolerance and limited age-related inflammation; (iii) uncover the genomic basis and evolution of extended healthspan and disease tolerance in bats; and, (iv) develop transgenic animal models to functionally validate the uncovered bat adaptations. We will generate 150 reference quality bat genomes, the novel immunological, bioinformatic, cellular and molecular tools required to take an integrative multi-omics approach and uncover the age and immune changes that occur in wild and captive bats across the ageing spectrum. We will identify the top regulators of longevity and immunity, using deep neural networks analyses, to functionally validate in our cellular systems and novel transgenic animal models- BatWorms and BatMice. Ultimately, we will provide a deeper understanding of extended healthspan and disease resistance and will pave the way for future therapeutics.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores